Finally, although this injection route delivers siRNA preferentially targeted to liver, this is a challenging process and it is necessary to administer PlGF siRNA repeatedly for the continuous knockdown of PlGF mRNA in vivo in order to prevent the progression of hepatic fibrosis. Here, PGF is linked to Hepatic fibrosis.